Skip to content
Head to head

Quest Diagnostics vs Thermo Fisher Scientific

Side-by-side on the measures that matter, with a plain-English read. Full detail: DGX · TMO

Updated moments ago

1-year performance, rebased to 100

DGX +40.5%TMO +18.4%
Thermo Fisher Scientific edges it on the scoreable measures. Thermo Fisher Scientific earns the most per share.
DGXTMO
Snapshot
SectorDiagnostics & ResearchDiagnostics & Research
Last price258.28669.54
Change today-0.31%-2.79%
1-year return+39.5%+17.2%
Market cap$28.42B$248.08B
52-week range168.34 – 263.19434.50 – 727.56
Valuation
P/E (TTM)25.7335.31
P/E percentile, own 5-yr range98th89th
P/B3.724.53
Dividend yield1.31%0.27%
Profitability & growth
EPS (TTM)8.7517.74
Net profit (TTM)$962.67M$6.57B
Revenue (TTM)$11.84B$47.35B
Provider revenue period date2026-09-292026-09-25
Revenue growth (YoY)+10.0%+9.1%
Gross margin33.1%41.1%
Operating margin14.6%18.7%
Net margin9.5%14.9%
Free cash flow (TTM)$1.38B$7.60B
Provider cash-flow period date2026-09-292026-09-25
Ownership & sentiment
Institutional ownership96.9%94.1%
Insider activity (12mo)38 buy / 10 sell20 buy / 30 sell
Short interest (% of float)3.4%1.3%
Analyst consensus50% buy / 50% hold (8)88% buy / 12% hold (16)
Analyst price target$260 (+1%)$778 (+16%)
StockVane view
StockVane Quant RatingC (83)C (61)
Company
Employees57,000125,000
Founded19901956

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.